Loading…

Predictors of residual viraemia in patients on long-term suppressive antiretroviral therapy

HIV-1-infected individuals with plasma RNA100,000 copies/ml and on-therapy RNA levels below detection limits of commercial assays for ≥ 6 months. Of 103 patients eligible for analysis, the median age was 46 years and the median duration of viral suppression was 4.8 years. 62% had detectable viraemia...

Full description

Saved in:
Bibliographic Details
Published in:Antiviral therapy 2013, Vol.18 (1), p.39-43
Main Authors: LU ZHENG, BOSCH, Ronald J, CHAN, Ellen S, READ, Sarah, KEARNEY, Mary, MARGOLIS, David M, MELLORS, John W, ERON, Joseph J, GANDHI, Rajesh T
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:HIV-1-infected individuals with plasma RNA100,000 copies/ml and on-therapy RNA levels below detection limits of commercial assays for ≥ 6 months. Of 103 patients eligible for analysis, the median age was 46 years and the median duration of viral suppression was 4.8 years. 62% had detectable viraemia (>0.2 copies/ml) by SCA (median 0.2 copies/ml, IQR 2 years (median 2.3 versus 0.2 copies/ml; P=0.016). Among HIV-1-infected patients with pre-ART HIV-1 RNA>100,000 copies/ml, residual viraemia was detectable in the majority (62%) despite many years of suppressive ART. Higher level viraemia was associated with older age and
ISSN:1359-6535
2040-2058
DOI:10.3851/IMP2323